CNS Disorders  >>  PF-02545920  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PF-02545920 / Pfizer
NCT01829048: A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia

Completed
1b
37
US
PF-02545920, Cohort 1, Cohort 2, Cohort 3, Placebo
Pfizer
Schizophrenia
10/13
10/13
NCT00463372: Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

Completed
1
40
RoW
PF-02545920
Pfizer
Schizophrenia, Schizo-affective Disorder
 
05/07

Download Options